CliffBio
biologic

Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized

Rho(D) Immune Globulin Intravenous (Human)

Loss of exclusivityMarch 2017projected — 12-year biologic exclusivity estimate
CompanyKamada Ltd. →See this company's full patent-cliff portfolio

Drug detail

Brand nameWinrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized
Active ingredientRho(D) Immune Globulin Intravenous (Human)
Strength1500IU
Dosage formInjection
RouteIntravenous
ModalityBiologic
FDA approvalMarch 2005
Marketing statusRx

More from Kamada Ltd.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized patent cliff — loss of exclusivity March 2017 | CliffBio